Valproate-induced metabolic changes in patients with epilepsy: Assessment with 1H-MRS

Epilepsia

Volumn 50, Issue 3, 2009, Pages 486-492

  Garcia, Meritxell ^a   Huppertz, Hans Juergen ^b   Ziyeh, Sargon ^c   Buechert, Martin ^d   Schumacher, Martin ^d   Mader, Irina ^d  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b SWISS EPILEPSY CENTER   (Switzerland)

^c Institute for Diagnostic Radiology   (Germany)

^d UNIVERSITY OF FREIBURG   (Germany)

Author keywords

1H MRS; Epilepsy; Hyperammonemia; Valproate

Indexed keywords

AMMONIA; ANTICONVULSIVE AGENT; CHOLINE; CREATINE; GLUTAMIC ACID; GLUTAMINE; INOSITOL; N ACETYLASPARTIC ACID; VALPROIC ACID;

ADULT; AMMONIA BLOOD LEVEL; ANTICONVULSANT THERAPY; ARTICLE; BRAIN METABOLISM; BRAIN MITOCHONDRION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; EPILEPSY; FEMALE; FOCAL EPILEPSY; HEPATIC ENCEPHALOPATHY; HUMAN; HYPERAMMONEMIA; MALE; MITOCHONDRIAL RESPIRATION; MYOCLONUS SEIZURE; PARIETAL LOBE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SEIZURE; TONIC CLONIC SEIZURE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTICONVULSANTS; ASPARTIC ACID; CHOLINE; CREATINE; ENERGY METABOLISM; EPILEPSIES, MYOCLONIC; EPILEPSIES, PARTIAL; EPILEPSY, TONIC-CLONIC; FEMALE; GLUTAMIC ACID; GLUTAMINE; HUMANS; HYPERAMMONEMIA; IMAGE PROCESSING, COMPUTER-ASSISTED; INOSITOL; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; OCCIPITAL LOBE; PARIETAL LOBE; REFERENCE VALUES; VALPROIC ACID; YOUNG ADULT;

EID: 61849106914     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2008.01801.x     Document Type: Article

References (38)

1. Baganz MD, Dross PE 1994) Valproic acid-induced hyperammonemic encephalopathy: MR appearance. AJNR Am J Neuroradiol 15 : 1779 1781.
2. Becker CM, Harris RA 1983) Influence of valproic acid on hepatic carbohydrate and lipid metabolism. Arch Biochem Biophys 223 : 381 392.
3. Binesh N, Huda A, Thomas MA, Wyckoff N, Bugbee M, Han S, Rasgon N, Davanzo P, Sayre J, Guze B, Martin P, Fawzy F 2006) Hepatic encephalopathy: a neurochemical, neuroanatomical, and neuropsychological study. J Appl Clin Med Phys 7 : 86 96.
4. van Calker D, Belmaker RH 2000) The high affinity inositol transport system-implications for the pathophysiology and treatment of bipolar disorder. Bipolar Disord 2 : 102 107.
5. Champe PC, Harvey RA, Ferrier DR 2005a) Lippincott's illustrated reviews: biochemistry. 3rd ed. Lippincott Williams & Wilkins, Baltimore and Philadelphia, pp. 251 253.
6. Champe PC, Harvey RA, Ferrier DR 2005b) Lippincott's illustrated reviews: biochemistry. 3rd ed. Lippincott Williams & Wilkins, Baltimore and Philadelphia, pp. 254 257.
7. Coulter DL, Allen RJ 1980) Secondary hyperammonaemia: a possible mechanism for valproate encephalopathy. Lancet 1 : 1310 1311.
8. Coulter DL, Allen RJ 1981) Hyperammonemia with valproic acid therapy. J Pediatr 99 : 317 319.
9. Eyer F, Felgenhauer N, Gempel K, Steimer W, Gerbitz KD, Zilker T 2005) Acute valproate poisoning: pharmacokinetics, alteration in fatty acid metabolism, and changes during therapy. J Clin Psychopharmacol 25 : 376 380.
10. Gal P, Oles KS, Gikman JT, Weaver R 1988) Valproic acid efficacy, toxicity, and pharmacokinetics in neonates with intractable seizures. Neurology 38 : 467 471.
11. Kandel ER, Schwartz JH, Jessell TM 2000) Principles of neural science. 4th ed. McGraw-Hill, New York, pp. 322 336.
12. Kojic J, Robertson PL, Quint DJ, Martin DM, Pang Y, Sundgren PC 2005) Brain glutamine by MRS in a patient with urea cycle disorder and coma. Pediatr Neurol 32 : 143 146.
13. Kreis R, Farrow N, Ross BD 1990) Diagnosis of hepatic encephalopathy by proton magnetic resonance spectroscopy. Lancet 336 : 635 636.
14. Kreis R, Farrow N, Ross BD 1991) Localized 1H NMR spectroscopy in patients with chronic hepatic encephalopathy. Analysis of changes in cerebral glutamine, choline and inositols. NMR Biomed 4 : 109 116.
15. Kreis R, Ross BD, Farrow N, Ackerman Z 1992) Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy. Radiology 182 : 19 27.
16. Kulick SK, Kramer DA 1993) Hyperammonemia secondary to valproic acid as a cause of lethargy in a postictal patient. Ann Emerg Med 22 : 610 612.
17. Lee JH, Seo DW, Lee YS, Kim ST, Mun CW, Lim TH, Min YI, Suh DJ 1999) Proton magnetic resonance spectroscopy (1H-MRS) findings for the brain in patients with liver cirrhosis reflect the hepatic functional reserve. Am J Gastroenterol 94 : 2206 2213.
18. Löscher W 1999) Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action. Prog Neurobiol 58 : 31 59.
19. Marini AM, Zaret B, Beckner RR 1988) Hepatic and renal contributions to valproic acid-induced hyperammonemia. Neurology 38 : 365 371.
20. McCall M, Bourgeois JA 2004) Valproic acid-induced hyperammonemia: a case report. J Clin Psychopharmacol 24 : 521 526.
21. Miese F, Kircheis G, Wittsack HJ, Wenserski F, Hemker J, Mödder U, Häussinger D, Cohnen M 2006) 1H-MR spectroscopy, magnetization transfer, and diffusion-weighted imaging in alcoholic and nonalcoholic patients with cirrhosis with hepatic encephalopathy. AJNR Am J Neuroradiol 27 : 1019 1026.
22. Nam SW, Kim JI, Park SH, Han NI, Han JY, Ahn BM, Kim JK, Choi SW, Chung KW, Sun HS, Yang DW, Ahn KJ, Lee JM 2003) A study for clinical correlation of neuropsychological test and brain magnetic resonance spectroscopy in patients with minimal hepatic encephalopathy. Korean J Gastroenterol 42 : 50 56.
23. Panda S, Radhakrishnan K 2004) Two cases of valproate-induced hyperammonemic encephalopathy without hepatic failure. J Assoc Physicians India 52 : 746 748.
24. Petroff OA, Rothman DL, Behar KL, Hyder F, Mattson RH 1999) Effects of valproate and other antiepileptic drugs on brain glutamate, glutamine, and GABA in patients with refractory complex partial seizures. Seizure 8 : 120 127.
25. Powell-Jackson PR, Tredger JM, Williams R 1984) Hepatotoxicity to sodium valproate: a review. Gut 25 : 673 681.
26. Provencher SW 1993) Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 30 : 672 679.
27. Rall TW, Schleifer LS 1990) Drugs effective in the therapy of the epilepsies. In Gilman AG, Rall TW, Nies AS, Taylor P (Eds) Goodman and Gilman's the pharmacology basis of therapeutics. 8th ed. Pergamon Press, New York, pp. 450 453.
28. Rose C, Kresse W, Kettenmann H 2005) Acute insult of ammonia leads to calcium-dependent glutamate release from cultured astrocytes, an effect of pH. J Biol Chem 280 : 20937 20944.
29. Ross B, Kreis R, Ernst T 1992) Clinical tools for the 90s: magnetic resonance spectroscopy and metabolite imaging. Eur J Radiol 14 : 128 140.
30. Segura-Bruna N, Rodriguez-Campello A, Puente V, Roquer J 2006) Valproate-induced hyperammonemic encephalopathy. Acta Neurol Scand 114 : 1 7.
31. Silva MFB, Rutter JPN, Ijlst L, Jakobs C, Duran M, Tavares De Almeida L, Wanders RJA 1997) Valproate inhibits the mitochondrial pyruvan-driven oxidative phosphorylation in vitro. J Inherit Metab Dis 20 : 397 400.
32. Simister RJ, McLean MA, Barker GJ, Duncan JS 2007) The effect of sodium valproate on proton MRS visible neurochemical concentrations. Epilepsy Res 74 : 215 219.
33. Srinivasan R, Cunningham C, Chen A, Vigneron D, Hurd R, Nelson S, Pelletier D 2005) TE-averaged two-dimensional proton spectroscopy imaging of glutamate at 3T. Neuroimage 30 : 1171 1178.
34. Taylor-Robinson SD, Sargentoni J, Marcus CD, Morgan MY, Bryant DJ 1994) Regional variations in cerebral proton spectroscopy in patients with chronic hepatic encephalopathy. Metab Brain Dis 9 : 347 359.
35. Thakur V, Rupar CA, Ramsay DA, Singh R, Fraser DD 2006) Fatal cerebral edema from late-onset ornithine transcarbamylase deficiency in a juvenile male patient receiving valproic acid. Pediatr Crit Care Med 7 : 273 276.
36. Zaret BS, Beckner RR, Marini AM, Wagle W, Passarelli C 1982) Sodium valproate-induced hyperammonemia without clinical hepatic dysfunction. Neurology 32 : 206 208.
37. Zaret BS, Marini AM 1985) Standardization in VPA-induced hyperammonemia. Neurology 35 : 136 137.
38. Ziyeh S, Thiel T, Spreer J, Klisch J, Schumacher M 2002) Valproate-induced encephalopathy: assessment with MR imaging and 1H MR spectroscopy. Epilepsia 43 : 1101 1105.